>
West Pharmaceutical Services Inc logo

WST - West Pharmaceutical Services Inc Share Price

$303.61 -2.8  -0.9%

Last Trade - 4:14pm

Sector
Healthcare
Size
Large Cap
Market Cap ÂŁ16.46bn
Enterprise Value ÂŁ16.20bn
Revenue ÂŁ1.56bn
Position in Universe 532nd / 6848
Bullish
Bearish
Unlock WST Revenue
Momentum
Relative Strength (%)
1m +7.49%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -1.82%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1,400 1,509 1,599 1,717 1,840 2,147 2,554 2,733 +8.9%
-25.8 +69.2 +44.4 -10.8 +15.8 +43.8 +31.0 +12.1
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, WestPharmaceutical Services Inc. revenues increased 17% to$2.15B. Net income increased 43% to $346.2M. Revenuesreflect Proprietary Products segment increase of 18% to$1.65B, Contract-Manufactured Products segment increase of13% to $498.6M, United States segment increase of 20% to$975.6M, Ireland segment increase of 30% to $226M, Germanysegment increase of 19% to $282.1M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for WST
Graphical History

Revenue

WST Revenue Unlock WST Revenue

Net Income

WST Net Income Unlock WST Revenue

Normalised EPS

WST Normalised EPS Unlock WST Revenue

PE Ratio Range

WST PE Ratio Range Unlock WST Revenue

Dividend Yield Range

WST Dividend Yield Range Unlock WST Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
WST EPS Forecasts Unlock WST Revenue
Profile Summary

West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated July 27, 1923
Public Since July 27, 1923
No. of Shareholders: 718
No. of Employees: 9,200
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 73,850,336
Free Float (0.0%)
Eligible for
ISAs
SIPPs
WST Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for WST
Upcoming Events for WST
Tuesday 20th April, 2021
Dividend For WST.N - 0.1700 USD
Wednesday 21st April, 2021 Estimate
Q1 2021 West Pharmaceutical Services Inc Earnings Release
Tuesday 4th May, 2021
West Pharmaceutical Services Inc Annual Shareholders Meeting
Wednesday 5th May, 2021 Estimate
West Pharmaceutical Services Inc Annual Shareholders Meeting
Wednesday 21st July, 2021 Estimate
Q2 2021 West Pharmaceutical Services Inc Earnings Release
Frequently Asked Questions for West Pharmaceutical Services Inc
What is the West Pharmaceutical Services Inc share price?

As of 4:14pm, shares in West Pharmaceutical Services Inc are trading at $303.61, giving the company a market capitalisation of ÂŁ16.46bn. This share price information is delayed by 15 minutes.

How has the West Pharmaceutical Services Inc share price performed this year?

Shares in West Pharmaceutical Services Inc are currently trading at $303.61 and the price has moved by 91.68% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the West Pharmaceutical Services Inc price has moved by 32.15% over the past year.

What are the analyst and broker recommendations for West Pharmaceutical Services Inc?

Of the analysts with advisory recommendations for West Pharmaceutical Services Inc, there are there are currently 2 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for West Pharmaceutical Services Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will West Pharmaceutical Services Inc next release its financial results?

West Pharmaceutical Services Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the West Pharmaceutical Services Inc dividend yield?

The West Pharmaceutical Services Inc dividend yield is 0.21% based on the trailing twelve month period.

Does West Pharmaceutical Services Inc pay a dividend?

Last year, West Pharmaceutical Services Inc paid a total dividend of 0.65, and it currently has a trailing dividend yield of 0.21%. Looking ahead, shares in West Pharmaceutical Services Inc are due to go ex-dividend on 2021-04-20 and the next dividend pay date is 2021-05-05.

When does West Pharmaceutical Services Inc next pay dividends?

West Pharmaceutical Services Inc are due to go ex-dividend on 2021-04-20 and the next dividend pay date is 2021-05-05. The historic dividend yield on West Pharmaceutical Services Inc shares is currently 0.21%.

How do I buy West Pharmaceutical Services Inc shares?

To buy shares in West Pharmaceutical Services Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of West Pharmaceutical Services Inc?

Shares in West Pharmaceutical Services Inc are currently trading at $303.61, giving the company a market capitalisation of ÂŁ16.46bn.

Where are West Pharmaceutical Services Inc shares listed? Where are West Pharmaceutical Services Inc shares listed?

Here are the trading details for West Pharmaceutical Services Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: WST
What kind of share is West Pharmaceutical Services Inc?

Based on an overall assessment of its quality, value and momentum, West Pharmaceutical Services Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a West Pharmaceutical Services Inc share price forecast 2021?

Shares in West Pharmaceutical Services Inc are currently priced at $303.61. At that level they are trading at 7.03% discount to the analyst consensus target price of 0.00.

Analysts covering West Pharmaceutical Services Inc currently have a consensus Earnings Per Share (EPS) forecast of 6.155 for the next financial year.

How can I tell whether the West Pharmaceutical Services Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like West Pharmaceutical Services Inc. Over the past six months, the relative strength of its shares against the market has been -11.24%. At the current price of $303.61, shares in West Pharmaceutical Services Inc are trading at 10.69% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the West Pharmaceutical Services Inc PE Ratio?

The West Pharmaceutical Services Inc PE ratio based on its reported earnings over the past 12 months is 65.2. The shares are currently trading at $303.61.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of West Pharmaceutical Services Inc?

West Pharmaceutical Services Inc's management team is headed by:

Patrick Zenner - NEC
Thomas Hofmann - IND
Mark Buthman - IND
William Feehery - IND
Eric Green - PRE
Annette Favorite - CHO
Quintin Lai - VPR
David Montecalvo - COO
Silji Abraham - SVP
Bernard Birkett - CFO
Robert Friel - IND
Chad Winters - CAO
Kimberly Mackay - SVP
Who are the major shareholders of West Pharmaceutical Services Inc?

Here are the top five shareholders of West Pharmaceutical Services Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 11.22% (8.29m shares)
T. Rowe Price Associates, Inc. Investment Advisor
Percentage owned: 6.26% (4.62m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.66% (4.18m shares)
Franklin Advisers, Inc. Investment Advisor/Hedge Fund
Percentage owned: 5.14% (3.80m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.53% (3.35m shares)
Similar to WST
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.